Biological characterization of ETP-46321 a selective and efficacious inhibitor of phosphoinositide-3-kinases-Reference-Cited by-同舟云学术

Biological characterization of ETP-46321 a selective and efficacious inhibitor of phosphoinositide-3-kinases

Published:2012-05-24 Issue:1 Volume:31 Page:66-76
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Granda Teresa G.,Cebrián David,Martínez Sonia,Anguita Patricia Villanueva,López Estela Casas,Link Wolfgang,Merino Teresa,Pastor Joaquín,Serelde Beatriz G.,Peregrina Sandra,Palacios Irene,Albarran Maria Isabel,Cebriá Antonio,Lorenzo Milagros,Alonso Patricia,Fominaya Jesús,López Ana Rodríguez,Bischoff James R.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-012-9835-5.pdf

Reference31 articles.

1. Yuan TL, Cantley LC (2008) PI3K pathway alterations in cancer: variations on a theme. Oncogene 27:5497–5510

2. Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, Willson JK, Markowitz S, Kinzler KW, Vogelstein B, Velculescu VE (2004) High frequency of mutations of the PIK3CA gene in human cancers. Science 304:554

3. Zhao L, Vogt PK (2008) Class I PI3K in oncogenic cellular transformation. Oncogene 27:5486–5496

4. Courtney KD, Corcoran RB, Engelman JA (2010) The PI3K pathway as drug target in human cancer. J Clin Oncol 28:1075–1083

5. Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP, Tonks NK (1998) The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci U S A 95:13513–13518

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aberrant angiogenic signaling pathways: Accomplices in ovarian cancer progression and treatment;Cellular Signalling;2024-08

2. Pharmaceutical and nutraceutical activation of FOXO3 for healthy longevity;Ageing Research Reviews;2022-06

3. Therapeutic strategies targeting FOXO transcription factors;Nature Reviews Drug Discovery;2020-11-10

4. The PI3K/mTOR dual inhibitor GSK458 potently impedes ovarian cancer tumorigenesis and metastasis;Cellular Oncology;2020-05-08

5. Morpholine as ubiquitous pharmacophore in medicinal chemistry: Deep insight into the structure-activity relationship (SAR);Bioorganic Chemistry;2020-03